Navigation Links
San Diego's Original Biotech Company Celebrates 30th Anniversary With Reunion
Date:9/9/2008

Hybritech Alumni Launched the World's 3rd Largest Biotech Cluster By

Developing more than 175 Local Companies

SAN DIEGO, Sept. 9 /PRNewswire/ -- The Hybritech Reunion Committee today announced the 30th Anniversary Reunion for Hybritech employees will take place on Saturday, September 13th, 2008 at the headquarters of AMN Healthcare in San Diego.

In September 1978 Hybritech, San Diego's "Granddaddy" biotech company, began operations in temporary trailers located in the parking lot of the La Jolla Cancer Research Foundation (now the renowned Burnham Institute). The company quickly produced the world's first commercially manufactured monoclonal antibody product, and soon thereafter, a series of diagnostic kits for allergy, pregnancy, anemia and certain forms of cancer. The company was also instrumental in the earliest investigations of in vivo and therapeutic applications of monoclonal antibodies for the diagnosis and treatment of cancer.

By 1985, Hybritech had developed its "Prostate Specific Antigen (PSA)" product, the first monoclonal antibody test for prostate cancer. The blood test soon became the standard method for physicians to diagnose and monitor prostate cancer patients, the second biggest cancer killer among American men.

In 1986, the pharmaceutical company, Eli Lilly paid $450 million in cash and warrants to buy Hybritech -- at that point the largest M&A in San Diego history. The company's early success -- and the visibility it created among its founders and employees -- spurred other academic scientists and entrepreneurs to form dozens of additional life sciences companies in San Diego.

Hybritech's original founders and employees have gone on to found more than 175 of the several hundred life science companies now located in San Diego county -- and comprising the San Diego life sciences "technology cluster".

"This event is a milestone celebration of all the tremendous things that came from the genesis of this small company 30 years ago. Who would have foreseen how significant the impact of one company could be on our community's economy and its reputation as a leading area of biotech research and scientific development? I am very proud to have led this brilliant, dedicated and innovative group of individuals," said Ted Greene, chief executive of Hybritech until the Lilly acquisition.

"There are several hundred Hybritech alumni who continue to live and work here in San Diego who plan to attend the reunion. We also have former employees planning to attend who currently live across the United States and in Europe -- and who are returning to San Diego for the event. These Hybritech alumni rank among the earliest founders of San Diego's now vibrant biotech and life sciences 'technology cluster'. Many people, even former employees, are surprised to learn that the Hybritech success has become a point of study among academic and governmental investigators who want to understand how 'technology clusters' are successfully created and sustained," said Cole Owen, a member of the Hybritech Reunion Committee.

The Hybritech 30th Anniversary Reunion (for former Hybritech employees only) will be held at the AMN Healthcare facility in San Diego, on Saturday, September 13, 2008, beginning at 3 PM. The host for the Reunion is AMN's President and CEO, Susan Nowakowski, herself a Hybritech alumnus.

Further registration information is available online at http://www.Hybritech.org for former Hybritech employees and media.

The Hybritech Reunion is a non profit corporation dedicated to preserving the legacy of Hybritech.


'/>"/>
SOURCE Hybritech Reunion Committee
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
2. Three Expert Opinion Journals now Publishing Original Research
3. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
4. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
5. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... July 20, 2017   KCNQ2 Cure Alliance ... evaluations company, today announced that they have completed ... genetic mutation implicated in KCNQ2 epileptic encephalopathy. They ... a second case involving an additional KCNQ2 genetic ... Alliance and Pairnomix entered into a collaboration to ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to make clinical trial sites and study participants truly unified. TrialKit, a native ... (FDA 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, ...
(Date:7/18/2017)... ... July 18, 2017 , ... Sourcing custom glass or quartz parts can be ... capabilities to properly execute your job can take many hours of emails, phone calls ... portal designed to showcase the company’s capabilities and core custom categories, and enables you ...
(Date:7/18/2017)... ... , ... G-CON today announced that it has received Notices ... Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean Room. The U.S. ... of G-CON’s R&D investments and validate the G-CON platform as a novel way ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):